Recent Finacing
Recent Raise
NewLink Genetics is an Ames, Iowa biotech developing HyperAcute therapeutic cancer vaccines for pancreatic, non‑small‑cell lung, and melanoma and an IDO‑inhibitor small molecule (D‑1MT), advancing through Phase I–II trials.
